Sharekhan

Lasa Supergenerics Ltd

Tue 29/04/2025,15:40:13 | NSE : LASA

₹ 17.73-0.09 (-0.51%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 17.82

Previous Close

₹ 17.82

Volume

69357

Mkt Cap ( Rs. Cr)

₹88.83

High

₹ 18.00

Low

₹ 17.56

52 Week High

₹ 33.49

52 Week Low

₹ 16.56

Book Value Per Share

₹ 19.30

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Lasa Supergenerics Ltd

Your Vote -

Buy

26.92%

Hold

3.85%

Sell

69.23%

26.92%

26 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Lasa Supergenerics - Press Release

    24 Apr 2025, 5:30PM Lasa Supergenerics Limited has informed the Exchange regarding a press release dated April 24, 2025, titled ""Press Release titled Lasa Supergenerics
  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Apr 2025, 5:26PM Press Release titled \ Lasa Supergenerics Limited Announces the Expansion of Manufacturing Capacity of API Albendazole to meet the growing demand\ iss
  • Lasa Supergenerics - Disclosure under SEBI Takeover Regulations

    19 Apr 2025, 11:11PM Omkar P Herlekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:20PM As of March 2025, 53.65% is owned by Indian Promoters and 46.35% by Public. <p align=justify> Top Promoter holding highest number of shares of Lasa Su
  • Lasa Supergenerics - General Updates

    18 Apr 2025, 3:58PM Lasa Supergenerics Limited has informed the Exchange about General Updates
  • Lasa Supergenerics - Declaration With Respect To Non- Applicabitlity Of Large Entity

    18 Apr 2025, 3:53PM Pursuant to SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26 th November , 2018 for fund raising by issuance of debt securities by large entitie
  • Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    18 Apr 2025, 3:26PM Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Apr 2025, 3:07PM Please find enclosed herewith certificate under regulation 74 (5)of SEBI (Depositories and Participants) Regulations, 2018 for quarter and the year en
  • Lasa Supergenerics - Trading Window-XBRL

    27 Mar 2025, 2:24PM LASA SUPERGENERICS LIMITED has informed the Exchange about Closure of Trading Window
  • Lasa Supergenerics - Trading Window

    27 Mar 2025, 2:20PM Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation
  • Lasa Supergenerics - Integrated Filing (Financial)

    4 Mar 2025, 5:08PM Pursuant to SEBI Circular No. SEBI /HO/CFD/CFD-PoD-2 /CIR/P/2024/185 Dated 31.12.2024, read with BSE circular and NSE circluar dated 02.01.2025. We ar
  • Lasa Supergenerics - Shareholders meeting

    25 Feb 2025, 5:37PM Lasa Supergenerics Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 22, 2025
  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    25 Feb 2025, 5:32PM In terms of the subject referred , the details regarding voting results of business transacted Extra ordinary General Meeting of the Company held on S
  • Lasa Supergenerics - Shareholders meeting

    22 Feb 2025, 10:50AM Lasa Supergenerics Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 22, 2025
  • Lasa Supergenerics posts Q3 net profit of Rs 5.49 cr

    13 Feb 2025, 7:20PM The company reported standalone net profit during the quarter stood at Rs 5.49 crore compared to net loss of Rs 1.46 crore in the previous year quarte
  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting Held Today On 13.02.2025 For The Quarter Ended Decmeb

    13 Feb 2025, 6:23PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar
  • Lasa Supergenerics - Outcome of Board Meeting

    13 Feb 2025, 6:22PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on February 13, 2025.
  • Lasa Supergenerics - Financial Result Updates

    13 Feb 2025, 6:20PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Lasa Supergenerics - General Updates

    11 Feb 2025, 3:47PM General Updates: Corrigendum to the Notice of EGM scheduled to be held on 22.02.2025
  • Lasa Supergenerics - Corrigendum To Notice Of EGM To Be Scheduled On 22.02.2025

    11 Feb 2025, 3:38PM The Company issued Notice of Extra -Ordinary General Meeting to the shareholders for the EGM to be held on Saturday, 22.02.2025 at 9.30 AM through vid
  • Lasa Supergenerics - Board Meeting Intimation

    5 Feb 2025, 4:26PM LASA SUPERGENERICS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to inter-alia consider and approve the Unaudited Fi
  • Lasa Supergenerics - Board Meeting Intimation for For The Quarter Ended On December 31, 2024.

    5 Feb 2025, 3:10PM Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider a
  • Lasa Supergenerics - Shareholders meeting

    30 Jan 2025, 6:42PM Lasa Supergenerics Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 22, 2025
  • Lasa Supergenerics - Notice Of Extraordinary General Meeting Of Members

    30 Jan 2025, 6:32PM Pursuant to Reg 30 of SEBI (LODR) Regulation 2015, we wish to inform you that the EOGM of the company will be held on saturday, February 22, 2025 at 9
  • Lasa Supergenerics to start trial runs from Nov 25

    23 Nov 2017 , 12:13PM Lasa Supergenerics announces that it will start its pilot production trial runs at its Unit IV from November 25, 2017

Key fundamentals

Evaluate the intrinsic value of Lasa Supergenerics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 96.6762 118.2859 148.6341 158.9171 175.9458
Liabilities 96.6762 118.2859 148.6341 158.9171 175.9458
Equity 50.1012 50.1012 40.6727 40.6727 40.6727
Gross Profit 2.1658 -6.5935 15.6327 47.221 29.948
Net Profit -21.7306 -38.6207 -5.3672 22.7777 3.6284
Cash From Operating Activities 2.1387 -17.3004 10.4898 41.3103 13.6224
NPM(%) -20.82 -29.8 -3.91 11.25 2.16
Revenue 104.335 129.5678 137.1267 202.3795 167.2712
Expenses 102.1692 136.1613 121.494 155.1585 137.3232
ROE(%) -22.47 -39.94 -5.55 23.56 3.75

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
16 Sep 2022 0.25 2.5 0 62.35
15 Sep 2021 0.25 2.5 0 73.6

Peers

Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 551.85 -0.37 20.39 159.87 35.34 0.54
Amines and Plasticizers Ltd 213.39 -0.13 28.53 97.50 361.94 0.23
Grauer and Weil (India) Ltd 115.60 0.00 32.66 401.72 322.62 0.43
HP Adhesives Ltd 53.28 1.02 25.01 162.80 111.94 0.00

Company Info

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Read More

Parent Organisation

Lasa Supergenerics Ltd.

Founded

11/11/2016

Managing Director

Dr.Omkar Pravin Herlekar

NSE Symbol

LASAEQ

FAQ

The current price of Lasa Supergenerics Ltd is ₹ 17.73.

The 52-week high for Lasa Supergenerics Ltd is ₹ 18.00 and the 52-week low is ₹ 17.56.

The market capitalization of Lasa Supergenerics Ltd is currently ₹ 88.83. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.

The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT